Search Orphan Drug Designations and Approvals
-
Generic Name: | (S)-2-(1-(9H-purin-6-ylamino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one) |
---|---|
Date Designated: | 12/18/2017 |
Orphan Designation: | Treatment of peripheral T-cell lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Rhizen Pharmaceuticals SA 40 Rue Fritz-Courvoisier La Chaux-de-Fonds, Neuchâtel Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-